Plasma lipoprotein assembly, remodeling, and clearance
REACTOME PATHWAYThe Plasma lipoprotein assembly, remodeling, and clearance pathway (Reactome ID: R-HSA-174824) involves 9 genes and is affected by 34 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Plasma lipoprotein assembly, remodeling, and clearance
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | hydroxyfasudil [Supplementary Concept] | — | 11 |
| 2 | Desmosterol | — | 300 |
| 3 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | — | 150 |
| 4 | Warfarin | — | 1,000 |
| 5 | Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of | — | 300 |
| 6 | Tolbutamide | — | 300 |
| 7 | cbd | — | 298 |
| 8 | egcg | — | 300 |
| 9 | cannabidiol | — | 296 |
| 10 | Catechin | — | 300 |
| 11 | Evans Blue | — | 300 |
| 12 | Olmesartan Medoxomil | — | 300 |
| 13 | Phenylbutazone | — | 300 |
| 14 | Trazodone | — | 297 |
| 15 | Niclosamide | — | 299 |
| 16 | Pueraria | — | 300 |
| 17 | Genistein | — | 300 |
| 18 | Resveratrol | — | 298 |
| 19 | amlexanox | — | 96 |
| 20 | kenpaullone | — | 8 |
| 21 | pd98059 | — | 7 |
| 22 | Riluzole | — | 298 |
| 23 | tyrphostin ag 1295 | — | 1 |
| 24 | Hesperidin | — | 300 |
| 25 | Bosentan | — | 298 |
| 26 | piericidin | — | 32 |
| 27 | Progesterone | — | 299 |
| 28 | Gemfibrozil | — | 297 |
| 29 | alpelisib | — | 227 |
| 30 | Diminazene | — | 300 |
| 31 | silver sulfadiazine | — | 299 |
| 32 | juglone hydroxylase [Supplementary Concept] catalyzes | — | 279 |
| 33 | Equilin | — | 216 |
| 34 | Sphingosine | — | 300 |
About the Plasma lipoprotein assembly, remodeling, and clearance Pathway
The Plasma lipoprotein assembly, remodeling, and clearance pathway is catalogued in Reactome (ID: R-HSA-174824) and involves 9 genes. In the BiohacksAI corpus, 34 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ALB, FURIN, NPC1, NR1H2, NR1H3.